GNTA
Genenta Science SpA ADR
NASDAQ: GNTA · HEALTHCARE · BIOTECHNOLOGY
$0.71
-1.99% today
Updated 2026-04-29
Market cap
$16.71M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.39
Dividend yield
—
52W range
$1 – $6
Volume
0.1M
Genenta Science SpA ADR (GNTA) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-38.00%
ROA
-17.70%
Debt/equity
0.62x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $0.00 | $-4.53M | — | — | — |
| 2020 | $0.00 | $-5.20M | — | — | — |
| 2021 | $0.00 | $-5.76M | — | — | — |
| 2022 | $0.00 | $-8.28M | — | — | — |
| 2023 | $0.00 | $-11.44M | — | — | — |
| 2024 | $0.00 | $-9.31M | — | — | — |
| 2025 | $0.00 | $-6.27M | — | — | — |